Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-10-31
pubmed:abstractText
To determine a recommended dose of once-weekly epoetin-beta administration for anemic cancer patients receiving myelosuppressive chemotherapy, we conducted a multicenter, randomized, double-blind trial.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0368-2811
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
655-61
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16987908-Adult, pubmed-meshheading:16987908-Aged, pubmed-meshheading:16987908-Anemia, pubmed-meshheading:16987908-Anthracyclines, pubmed-meshheading:16987908-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16987908-Bridged Compounds, pubmed-meshheading:16987908-Dose-Response Relationship, Drug, pubmed-meshheading:16987908-Double-Blind Method, pubmed-meshheading:16987908-Drug Administration Schedule, pubmed-meshheading:16987908-Erythrocyte Transfusion, pubmed-meshheading:16987908-Erythropoietin, pubmed-meshheading:16987908-Female, pubmed-meshheading:16987908-Hemoglobins, pubmed-meshheading:16987908-Humans, pubmed-meshheading:16987908-Leukopenia, pubmed-meshheading:16987908-Lung Neoplasms, pubmed-meshheading:16987908-Lymphoma, pubmed-meshheading:16987908-Male, pubmed-meshheading:16987908-Middle Aged, pubmed-meshheading:16987908-Platinum Compounds, pubmed-meshheading:16987908-Quality of Life, pubmed-meshheading:16987908-Recombinant Proteins, pubmed-meshheading:16987908-Taxoids
pubmed:year
2006
pubmed:articleTitle
Once-weekly epoetin-beta improves hemoglobin levels in cancer patients with chemotherapy-induced anemia: A randomized, double-blind, dose-finding study.
pubmed:affiliation
Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan. ymorisim@aichi-cc.jp
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study